Ospedale Galeazzi S.p.A.

Rheumatology and Crystal Arthropathy

Clinical research in calcium pyrophosphate deposition disease with attention to synovial membrane inflammation and tissue-level inflammatory activity.

  • CPPD
  • Synovial tissue inflammation
  • CD68 inflammatory scoring

The sponsor’s activity in this area reflects interest in musculoskeletal inflammation and objective assessment of joint tissue involvement.

Cardiovascular Disease in Postmenopausal Osteoporosis

Research focused on coronary atherosclerotic damage in women with postmenopausal osteoporosis, linking skeletal health with vascular disease.

  • Coronary atherosclerosis
  • Coronary CT assessment
  • Women’s cardiovascular health

Trials in this field examine the relationship between bone fragility and atherosclerotic progression in a female population.

Bone Metabolism and Osteoporosis Care

Clinical interest extends to therapeutic management of postmenopausal osteoporosis, with evaluation of agents used in routine care for bone health.

  • Osteoporosis treatment
  • Bone remodeling
  • Postmenopausal women

This area connects skeletal disease management with concurrent assessment of cardiovascular outcomes.

Inflammation and Targeted Therapeutics

Research activity includes evaluation of therapies directed at immune-mediated inflammation and tissue response in joint disease.

  • Inflammatory pathways
  • Immune modulation
  • Musculoskeletal disease

The sponsor’s portfolio shows interest in both rheumatic conditions and cardiometabolic complications associated with chronic disease.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Baricitinib for Patients with Calcium Pyrophosphate Deposition Disease (CPPD) Using Methotrexate Sodium and Drug Combination

    Recruiting

    1 1 1
    Italy
  • Comparing the effect of romosozumab and denosumab on coronary artery damage in women with postmenopausal osteoporosis

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy